DelSite

DelSite has developed an innovative drug delivery technology for providing silicone-based drug dosages. The company’s technology develops and licenses long-term, controlled drug delivery implants, as well as subcutaneous and intramuscular formulations, to address significant unmet medical and commercial needs, enabling clinicians to access more patient-friendly products.